1. Anti-infection Cell Cycle/DNA Damage Epigenetics Autophagy Apoptosis Metabolic Enzyme/Protease
  2. SARS-CoV Deubiquitinase DNA Methyltransferase Autophagy Apoptosis Endogenous Metabolite
  3. 6-Thioguanine

6-Thioguanine  (Synonyms: Thioguanine; 2-Amino-6-purinethiol)

Cat. No.: HY-13765 Purity: 99.54%
Handling Instructions Technical Support

6-Thioguanine (Thioguanine; 2-Amino-6-purinethiol) is an anti-leukemia and immunosuppressant agent, acts as an inhibitor of SARS and MERS coronavirus papain-like proteases (PLpros) and also potently inhibits USP2 activity, with IC50s of 25 μM and 40 μM for Plpros and recombinant human USP2, respectively.

For research use only. We do not sell to patients.

CAS No. : 154-42-7

Size Price Stock Quantity
Free Sample (0.1 - 0.2 mg)   Apply Now  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
100 mg In-stock
500 mg In-stock
1 g   Get quote  
5 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 13 publication(s) in Google Scholar

Other Forms of 6-Thioguanine:

Top Publications Citing Use of Products

    6-Thioguanine purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2025 Mar 13;13(3):e010639.  [Abstract]

    Representative images of the HPRT mutability assay in SW480 and DLD-1 cells treated with 6-Thioguanine (5 µM) were shown.

    6-Thioguanine purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2025 Mar 13;13(3):e010639.  [Abstract]

    Representative images of the HPRT mutability assay in CT26 and SW480 cells were presented. On the left, CT26 and SW480 cells were treated with 6-TG (5 µM) with or without EPZ020411 (2 µM) for 2 weeks. On the right, CT26 and SW480 cells were treated with EPZ020411 (4 µM) for 4 weeks, and the survived cells were termed CT26T or SW480T. The HPRT mutability assay was performed in CT26 and CT26T or SW480 and SW480T treated with 6-TG alone (4 µM).

    6-Thioguanine purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 May:71:103112.  [Abstract]

    Cells were infected with PDCoV in media supplemented with the indicated concentrations of 6-Thioguanine (0, 1, or 5 μM).

    6-Thioguanine purchased from MedChemExpress. Usage Cited in: Front Oncol. 2024 Jul 19:14:1440650.  [Abstract]

    Human plasma-like media (HPLM) attenuated leukemic cell sensitivity to thiopurine chemotherapeutics. Dose-response curves for 6-thioguanine in leukemic cells (NALM-6, REH) in regular or HPLM media were shown. Leukemic cell viability was assessed after 48 hours of drug treatment using the CellTiter-Glo Luminescent Cell Viability Assay.

    6-Thioguanine purchased from MedChemExpress. Usage Cited in: Front Oncol. 2024 Jul 19:14:1440650.  [Abstract]

    Caspase-3/7 activity was assessed in leukemia cells cultured in HPLM or regular media after 48 hours of treatment with 6-Thioguanine (10 μM).

    View All Deubiquitinase Isoform Specific Products:

    View All DNA Methyltransferase Isoform Specific Products:

    View All Endogenous Metabolite Isoform Specific Products:

    • Biological Activity

    • Protocol

    • Purity & Documentation

    • References

    • Customer Review

    Description

    6-Thioguanine (Thioguanine; 2-Amino-6-purinethiol) is an anti-leukemia and immunosuppressant agent, acts as an inhibitor of SARS and MERS coronavirus papain-like proteases (PLpros) and also potently inhibits USP2 activity, with IC50s of 25 μM and 40 μM for Plpros and recombinant human USP2, respectively.

    IC50 & Target

    IC50: 25 μM (PLpros), 40 μM (Recombinant human USP2)[3]

    Cellular Effect
    Cell Line Type Value Description References
    A549 IC50
    2.82 μM
    Compound: 6-thioguanine
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    [PMID: 20605656]
    ASPC1 IC50
    2.8 μM
    Compound: 6-TG
    Cytotoxicity against human Aspc-1 cells by crystal violet staining
    Cytotoxicity against human Aspc-1 cells by crystal violet staining
    [PMID: 20930123]
    CCRF-CEM EC50
    0.8701 μM
    Compound: 6-thioguanine
    Cytotoxicity against human CCRF-CEM cells after 48 hrs by cell titer-blue assay
    Cytotoxicity against human CCRF-CEM cells after 48 hrs by cell titer-blue assay
    [PMID: 19743858]
    CCRF-CEM EC50
    0.9416 μM
    Compound: 6-thioguanine
    Cytotoxicity against human CCRF-CEM/C2 cells after 48 hrs by cell titer-blue assay
    Cytotoxicity against human CCRF-CEM/C2 cells after 48 hrs by cell titer-blue assay
    [PMID: 19743858]
    CCRF-CEM IC50
    2.98 μM
    Compound: 6-thioguanine
    Cytotoxicity against human CEM cells after 72 hrs by MTT assay
    Cytotoxicity against human CEM cells after 72 hrs by MTT assay
    [PMID: 20605656]
    COLO357 IC50
    2.09 μM
    Compound: 6-TG
    Cytotoxicity against human Colo-357 cells by crystal violet staining
    Cytotoxicity against human Colo-357 cells by crystal violet staining
    [PMID: 20930123]
    Caco-2 CC50
    2.21 μM
    Compound: TIOGUANINE
    Toxicity against Caco-2 cells determined at 48 hours by intracellular ATP concentration using the CellTiter-Glo Luminescent Cell Viability Assay
    Toxicity against Caco-2 cells determined at 48 hours by intracellular ATP concentration using the CellTiter-Glo Luminescent Cell Viability Assay
    10.21203/rs.3.rs-23951/v1
    Caco-2 IC50
    1.71 μM
    Compound: TIOGUANINE
    Determination of IC50 values for inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells after 48 hours by high content imaging
    Determination of IC50 values for inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells after 48 hours by high content imaging
    10.21203/rs.3.rs-23951/v1
    DAN-G IC50
    4.32 μM
    Compound: 6-TG
    Cytotoxicity against human DAN-G cells by crystal violet staining
    Cytotoxicity against human DAN-G cells by crystal violet staining
    [PMID: 20930123]
    HEK-293T EC50
    3.6 μM
    Compound: 6-TG
    Antiproliferative activity against HEK293T cells with high HGPRT expression incubated for 48 hrs by CellTiter-Glo2 assay
    Antiproliferative activity against HEK293T cells with high HGPRT expression incubated for 48 hrs by CellTiter-Glo2 assay
    [PMID: 36374020]
    HL-60 EC50
    3.897 μM
    Compound: 6-thioguanine
    Cytotoxicity against human HL60 cells after 48 hrs by cell titer-blue assay
    Cytotoxicity against human HL60 cells after 48 hrs by cell titer-blue assay
    [PMID: 19743858]
    HL60/MX2 EC50
    3.649 μM
    Compound: 6-thioguanine
    Cytotoxicity against human HL60/MX2 cells after 48 hrs by cell titer-blue assay
    Cytotoxicity against human HL60/MX2 cells after 48 hrs by cell titer-blue assay
    [PMID: 19743858]
    HT-29 IC50
    1240 nM
    Compound: Thioquanine
    Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay
    Antiproliferative activity against human HT-29 cells after 96 hrs by MTT assay
    [PMID: 2778449]
    Jurkat GI50
    13 μM
    Compound: thioguanine
    Growth inhibition of Jurkat cell
    Growth inhibition of Jurkat cell
    [PMID: 17181155]
    Jurkat GI50
    147 μM
    Compound: thioguanine
    Growth inhibition of Jurkat cell overexpressing Bcl2
    Growth inhibition of Jurkat cell overexpressing Bcl2
    [PMID: 17181155]
    Jurkat GI50
    183 μM
    Compound: thioguanine
    Growth inhibition of Jurkat cell overexpressing BclXL
    Growth inhibition of Jurkat cell overexpressing BclXL
    [PMID: 17181155]
    K562 EC50
    0.74 μM
    Compound: 6-TG
    Antiproliferative activity against human K562 cells with low HGPRT expression incubated for 48 hrs by CellTiter-Glo2 assay
    Antiproliferative activity against human K562 cells with low HGPRT expression incubated for 48 hrs by CellTiter-Glo2 assay
    [PMID: 36374020]
    K562 IC50
    1.54 μM
    Compound: 6-thioguanine
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    Cytotoxicity against human K562 cells after 72 hrs by MTT assay
    [PMID: 20605656]
    K562 IC50
    3.9 μM
    Compound: 6-thioguanine
    Cytotoxicity against human paclitaxel-resistant K562 cells after 72 hrs by MTT assay
    Cytotoxicity against human paclitaxel-resistant K562 cells after 72 hrs by MTT assay
    [PMID: 20605656]
    P388 IC50
    300 nM
    Compound: Thioquanine
    Antiproliferative activity against mouse P388 cells after 48 hrs by MTT assay
    Antiproliferative activity against mouse P388 cells after 48 hrs by MTT assay
    [PMID: 2778449]
    PANC-1 IC50
    8.31 μM
    Compound: 6-TG
    Cytotoxicity against human PANC1 cells by crystal violet staining
    Cytotoxicity against human PANC1 cells by crystal violet staining
    [PMID: 20930123]
    PaTu 8988t IC50
    3.43 μM
    Compound: 6-TG
    Cytotoxicity against human Patu-T cells by crystal violet staining
    Cytotoxicity against human Patu-T cells by crystal violet staining
    [PMID: 20930123]
    THP-1 EC50
    0.27 μM
    Compound: 6-TG
    Antiproliferative activity against human THP-1 cells with low HGPRT expression incubated for 48 hrs by CellTiter-Glo2 assay
    Antiproliferative activity against human THP-1 cells with low HGPRT expression incubated for 48 hrs by CellTiter-Glo2 assay
    [PMID: 36374020]
    Vero C1008 CC50
    35.5 μM
    Compound: 26
    Cytotoxicity against African green monkey Vero E6 cells assessed as cell viability
    Cytotoxicity against African green monkey Vero E6 cells assessed as cell viability
    [PMID: 35620927]
    In Vitro

    6-Thioguanine (Thioguanine; 2-Amino-6-purinethiol) is an anti-leukemia and immunosuppressant agent, acts as an inhibitor of SARS and MERS coronavirus papain-like proteases (PLpros) and also potently inhibits USP2 activity, with IC50s of 25 μM and 40 μM for Plpros and recombinant human USP2, respectively[1]. 6-Thioguanine (Thioguanine) affects the methylation of cytosine residues by purified DNA methyltransferases including human DNMT1 and bacterial HpaII methylase. 6-Thioguanine (Thioguanine) (1 or 3 μM) decreases global cytosine methylation in Jurkat T cells and cytosine methylation in human cells at 3 μM[2]. 6-Thioguanine (Thioguanine) (18.75, 37.50, or 75.00 μM) adversely affects cell viability, but with no effect on LDH or ALT activity[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Clinical Trial
    Molecular Weight

    167.20

    Formula

    C5H5N5S

    CAS No.
    Appearance

    Solid

    Color

    White to yellow

    SMILES

    SC1=NC(N)=NC2=C1N=CN2

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 6 months
    -20°C 1 month
    Solvent & Solubility
    In Vitro: 

    1 M NaOH : ≥ 100 mg/mL (598.09 mM)

    DMSO : 10 mg/mL (59.81 mM; Need ultrasonic and warming; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    *"≥" means soluble, but saturation unknown.

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 5.9809 mL 29.9043 mL 59.8086 mL
    5 mM 1.1962 mL 5.9809 mL 11.9617 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 1.67 mg/mL (9.99 mM); Clear solution

      This protocol yields a clear solution of ≥ 1.67 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (16.7 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.54%

    References
    Cell Assay
    [3]

    Treatments consists of 3 thiopurines (azathioprine, 6-mercaptopurine, and 6-Thioguanine (Thioguanine)) at each of 6 concentrations (0.468, 0.937, 1.875, 3.750, 7.500, and 15.000 μM). Each thiopurinee is dissolved in DMSO solution to achieve a concentration of 10 mg/mL. Sterile filtered maintenance medium is used to further dilute each thiopurine solution to each of the 6 treatment concentrations. Twenty-four hours after the hepatocytes are plated on 96-well culture[3].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO / 1 M NaOH 1 mM 5.9809 mL 29.9043 mL 59.8086 mL 149.5215 mL
    5 mM 1.1962 mL 5.9809 mL 11.9617 mL 29.9043 mL
    10 mM 0.5981 mL 2.9904 mL 5.9809 mL 14.9522 mL
    15 mM 0.3987 mL 1.9936 mL 3.9872 mL 9.9681 mL
    20 mM 0.2990 mL 1.4952 mL 2.9904 mL 7.4761 mL
    25 mM 0.2392 mL 1.1962 mL 2.3923 mL 5.9809 mL
    30 mM 0.1994 mL 0.9968 mL 1.9936 mL 4.9841 mL
    40 mM 0.1495 mL 0.7476 mL 1.4952 mL 3.7380 mL
    50 mM 0.1196 mL 0.5981 mL 1.1962 mL 2.9904 mL
    1 M NaOH 60 mM 0.0997 mL 0.4984 mL 0.9968 mL 2.4920 mL
    80 mM 0.0748 mL 0.3738 mL 0.7476 mL 1.8690 mL
    100 mM 0.0598 mL 0.2990 mL 0.5981 mL 1.4952 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    6-Thioguanine
    Cat. No.:
    HY-13765
    Quantity:
    MCE Japan Authorized Agent: